# Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

> **NCT00350025** · PHASE2 · COMPLETED · sponsor: **Fox Chase Cancer Center** · enrollment: 41 (actual)

## Conditions studied

- Urologic Neoplasm

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00350025
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2010-07
- **Final completion:** 2012-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00350025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00350025, "Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00350025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*